Longitudinal study on mitochondrial effects of didanosine-tenofovir combinationLOPEZ, Sonia; NEGREDO, Eugènia; CLOTET, Bonaventura et al.AIDS research and human retroviruses. 2006, Vol 22, Num 1, pp 33-39, issn 0889-2229, 7 p.Article

Immunological and virological effects of structured treatment interruptions following exposure to hydroxyurea plus didanosineBENITO, José Miguel; LOPEZ, Mariola; BALLESTEROS, Celia et al.AIDS research and human retroviruses. 2006, Vol 22, Num 8, pp 734-743, issn 0889-2229, 10 p.Article

Didanosine causes sensory neuropathy in an HIV/AIDS animal model : Impaired mitochondrial and neurotrophic factor gene expressionYU ZHU; ANTONY, Joseph M; MARTINEZ, Jose A et al.Brain. 2007, Vol 130, pp 2011-2023, issn 0006-8950, 13 p., 8Article

Survival effects of ZDV, ddI, and ddC in patients with CD4 ≤50 cells/mm³KAZEM KAZEMPOUR; KAMMERMAN, L. A; FARR, S. S et al.Journal of acquired immune deficiency syndromes and human retrovirology. 1995, Vol 10, pp S97-S106, issn 1077-9450, SUP2Conference Paper

Efficacy and Safety of Unboosted Atazanavir in Combination with Lamivudine and Didanosine in Naive HIV Type 1 Patients in SenegalLANDMAN, R; DIALLO, M. B; GIRARD, P. M et al.AIDS research and human retroviruses. 2010, Vol 26, Num 5, pp 519-525, issn 0889-2229, 7 p.Article

Didanosine in HIV-1-infected patients experiencing failure of antiretroviral therapy : A randomized placebo-controlled trialMOLINA, Jean-Michel; MARCELIN, Anne-Geneviève; PAVIE, Juliette et al.The Journal of infectious diseases. 2005, Vol 191, Num 6, pp 840-847, issn 0022-1899, 8 p.Article

A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infectionDYBUL, Mark; NIES-KRASKE, Elizabeth; METCALF, Julia A et al.The Journal of infectious diseases. 2004, Vol 189, Num 11, pp 1974-1982, issn 0022-1899, 9 p.Article

Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: A randomized, placebo-controlled trial, ACTG 307FRANK, Ian; BOSCH, Ronald J; FOX, Lawrence et al.AIDS research and human retroviruses. 2004, Vol 20, Num 9, pp 916-926, issn 0889-2229, 11 p.Article

Pharmacokinetics of coadministered ritonavir-boosted elvitegravir and zidovudine, didanosine, stavudine, or abacavirRAMANATHAN, Srinivasan; GONG SHEN; HINKLE, John et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, Num 2, pp 160-166, issn 1525-4135, 7 p.Article

DidanosineLa Revue Prescrire. 2000, Vol 20, Num 209, issn 0247-7750, p. 587Article

Mitochondrial Tubulopathy in Tenofovir Disoproxil Fumarate-Treated RatsLEBRECHT, Dirk; VENHOFF, Ana C; KIRSCHNER, Janbernd et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 51, Num 3, pp 258-263, issn 1525-4135, 6 p.Article

Severe liver disease associated with prolonged exposure to antiretroviral drugsMAIDA, Ivana; NUNEZ, Marina; GARCIA-SAMANIEGO, Javier et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 42, Num 2, pp 177-182, issn 1525-4135, 6 p.Article

Optimal suppression of HIV replication by low-dose hydroxyurea through the combination of antiviral and cytostatic ('virostatic') mechanismsLORI, Franco; FOLI, Andrea; GROFF, Antonella et al.AIDS (London). 2005, Vol 19, Num 11, pp 1173-1181, issn 0269-9370, 9 p.Article

Development and validation of a HPLC-UV method for the determination in didanosine tabletsCAVALCANTI DE OLIVEIRA, Antonia Maria; RAPOSO LÖWEN, Teresa Cristina; MENDES CABRAI, Lucio et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 38, Num 4, pp 751-756, issn 0731-7085, 6 p.Article

Comparative Analysis of Genetic Toxicity of AZTand ddl Antiretrovirals in Somatic Cells of Drosophila melanogasferNASCIMENTO GUIMARAES, Nilza; PEREIRA, Karla De Castro; RODRIGUES DE ANDRADE, Heloisa Helena et al.Environmental and molecular mutagenesis (Print). 2008, Vol 49, Num 4, pp 312-317, issn 0893-6692, 6 p.Article

Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid cellsCARTER, Meghan M; TORRES, Salina M; COOK, Dennis L et al.Environmental and molecular mutagenesis (Print). 2007, Vol 48, Num 3-4, pp 239-247, issn 0893-6692, 9 p.Article

Hydroxyurea plus didanosine as maintenance therapy after 1 year on highly active antiretroviral therapyBARREIRO, P; DE MENDOZA, C; SORIANO, V et al.AIDS (London). 2000, Vol 14, Num 2, pp 207-208, issn 0269-9370Article

Immunotoxicity of 2',3'-dideoxyinosine in female B6C3F1 micePHILLIPS, K. E; MCCAY, J. A; BROWN, R. D et al.Drug and chemical toxicology (New York, NY. 1978). 1997, Vol 20, Num 3, pp 189-228, issn 0148-0545Article

Assessment of developmental toxicity of antiretroviral drugs using a rat whole embryo culture systemFUJINAGA, M; SCHULTE, M; HOLODNIY, M et al.Teratology (Philadelphia, PA). 2000, Vol 62, Num 2, pp 108-114, issn 0040-3709Article

Target cell availability and the successful suppression of HIV by hydroxyurea and didanosineDE BOER, R. J; BOUCHER, C. A. B; PERELSON, A. S et al.AIDS (London). 1998, Vol 12, Num 13, pp 1567-1570, issn 0269-9370Article

A trial comparing nucleoside monotherapy with sequential therapy with 3 drugs in HIV-infected patientsROCA, B; OLMOS, P; MINGUEZ, C et al.Scandinavian journal of infectious diseases. 1998, Vol 30, Num 4, pp 426-428, issn 0036-5548Article

Ca²⁺ dependency of diadenosine 5',5-p,p-tetraphosphate degradation in dog plasmaIWATA, K; NAKAJIMA, H; KIMURA, T et al.Biological & pharmaceutical bulletin. 1995, Vol 18, Num 5, pp 788-790, issn 0918-6158Article

Transport properties of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine in the rat choroid plexusTAKASAWA, K; SUZUKI, H; SUGIYAMA, Y et al.Biopharmaceutics & drug disposition. 1997, Vol 18, Num 7, pp 611-622, issn 0142-2782Article

Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infectionFLANDRE, Philippe; CHAPPEY, Colombe; MARCELIN, Anne Genevieve et al.The Journal of infectious diseases. 2007, Vol 195, Num 3, pp 392-398, issn 0022-1899, 7 p.Article

Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HN-1-infected adults with viral suppression receiving a protease inhibitor-based regimen : A randomized trialMOLINA, Jean-Michel; JOURNOT, Valérie; GOUJARD, Cécile et al.The Journal of infectious diseases. 2005, Vol 191, Num 6, pp 830-839, issn 0022-1899, 10 p.Article